These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 31147526)

  • 1.
    Zhou JD; Li XX; Zhang TJ; Xu ZJ; Zhang ZH; Gu Y; Wen XM; Zhang W; Ji RB; Deng ZQ; Lin J; Qian J
    Aging (Albany NY); 2019 May; 11(10):3376-3391. PubMed ID: 31147526
    [No Abstract]   [Full Text] [Related]  

  • 2. Tumor suppressor miR-139-5p targets Tspan3 and regulates the progression of acute myeloid leukemia through the PI3K/Akt pathway.
    Zhang R; Tang P; Wang F; Xing Y; Jiang Z; Chen S; Meng X; Liu L; Cao W; Zhao H; Ma P; Chen Y; An C; Sun L
    J Cell Biochem; 2019 Mar; 120(3):4423-4432. PubMed ID: 30367526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic dysregulation of ID4 predicts disease progression and treatment outcome in myeloid malignancies.
    Zhou JD; Zhang TJ; Li XX; Ma JC; Guo H; Wen XM; Zhang W; Yang L; Yan Y; Lin J; Qian J
    J Cell Mol Med; 2017 Aug; 21(8):1468-1481. PubMed ID: 28452111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circ_0009910 sponges miR-491-5p to promote acute myeloid leukemia progression through modulating B4GALT5 expression and PI3K/AKT signaling pathway.
    Wu Y; Zhao B; Chen X; Geng X; Zhang Z
    Int J Lab Hematol; 2022 Apr; 44(2):320-332. PubMed ID: 34709725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CXCL8 derived from mesenchymal stromal cells supports survival and proliferation of acute myeloid leukemia cells through the PI3K/AKT pathway.
    Cheng J; Li Y; Liu S; Jiang Y; Ma J; Wan L; Li Q; Pang T
    FASEB J; 2019 Apr; 33(4):4755-4764. PubMed ID: 30592634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-193a represses c-kit expression and functions as a methylation-silenced tumor suppressor in acute myeloid leukemia.
    Gao XN; Lin J; Li YH; Gao L; Wang XR; Wang W; Kang HY; Yan GT; Wang LL; Yu L
    Oncogene; 2011 Aug; 30(31):3416-28. PubMed ID: 21399664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor suppressor miR-520a inhibits cell growth by negatively regulating PI3K/AKT signaling pathway in acute myeloid leukemia.
    Xiao J; Wan F; Tian L; Li Y
    Adv Clin Exp Med; 2024 Jul; 33(7):729-738. PubMed ID: 37855060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-338-3p Plays a Significant Role in Casticin-Induced Suppression of Acute Myeloid Leukemia via Targeting PI3K/Akt Pathway.
    Yu K; Wang J; Hou J; Zhang L; Liang H
    Biomed Res Int; 2022; 2022():9214130. PubMed ID: 35765408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of Long Non-Coding RNA LINC01268 on the Malignant Biological Behaviors of Acute Myeloid Leukemia Cells].
    Chen W; Gan DY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Dec; 31(6):1608-1616. PubMed ID: 38071035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytoplasmic localization of wild-type survivin is associated with constitutive activation of the PI3K/Akt signaling pathway and represents a favorable prognostic factor in patients with acute myeloid leukemia.
    Serrano-López J; Serrano J; Figueroa V; Torres-Gomez A; Tabares S; Casaño J; Fernandez-Escalada N; Sánchez-Garcia J
    Haematologica; 2013 Dec; 98(12):1877-85. PubMed ID: 23812937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long noncoding RNA LINC00265 predicts the prognosis of acute myeloid leukemia patients and functions as a promoter by activating PI3K-AKT pathway.
    Ma L; Kuai WX; Sun XZ; Lu XC; Yuan YF
    Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7867-7876. PubMed ID: 30536332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The PI3K-Akt-mTOR Signaling Pathway in Human Acute Myeloid Leukemia (AML) Cells.
    Nepstad I; Hatfield KJ; Grønningsæter IS; Reikvam H
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32326335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TET1-mediated microRNA-188-5p promoter hydroxymethylation regulates PTEN/PI3K/AKT signaling pathway in acute myeloid leukemia cells.
    Lu N; Wang X; Wang W; Tang M; Chen J; You H; Wang D
    Arch Biochem Biophys; 2023 Mar; 736():109523. PubMed ID: 36682704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High HSPA8 expression predicts adverse outcomes of acute myeloid leukemia.
    Li J; Ge Z
    BMC Cancer; 2021 Apr; 21(1):475. PubMed ID: 33926391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. c-Myc suppresses miR-451⊣YWTAZ/AKT axis via recruiting HDAC3 in acute myeloid leukemia.
    Su R; Gong JN; Chen MT; Song L; Shen C; Zhang XH; Yin XL; Ning HM; Liu B; Wang F; Ma YN; Zhao HL; Yu J; Zhang JW
    Oncotarget; 2016 Nov; 7(47):77430-77443. PubMed ID: 27764807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-183 promotes cell proliferation via regulating programmed cell death 6 in pediatric acute myeloid leukemia.
    Wang X; Zuo D; Yuan Y; Yang X; Hong Z; Zhang R
    J Cancer Res Clin Oncol; 2017 Jan; 143(1):169-180. PubMed ID: 27738758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of SMIM3 inhibits growth of leukemia via PI3K-AKT signaling pathway and correlates with prognosis of adult acute myeloid leukemia with normal karyotype.
    Liu Y; Chen Y; Liu Y; Li M; Zhang Y; Shi L; Yang L; Li T; Li Y; Jiang Z; Liu Y; Wang C; Wang S
    J Transl Med; 2022 Dec; 20(1):612. PubMed ID: 36550462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study on the correlation between Chinese medical syndrome types and ID4 gene promoter methylation in human acute myeloid leukemia].
    Liu F; Xu RR
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2012 Apr; 32(4):471-3. PubMed ID: 22803425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ZEB1 serves as an oncogene in acute myeloid leukaemia via regulating the PTEN/PI3K/AKT signalling pathway by combining with P53.
    Li L; Feng Y; Hu S; Du Y; Xu X; Zhang M; Peng X; Chen F
    J Cell Mol Med; 2021 Jun; 25(11):5295-5304. PubMed ID: 33960640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [MiR-217 Targeting PI3K/Akt Pathway Enhances Sensitivity of Adriamycin to Acute Myeloid Leukemia].
    Gan DY; Wu J; Zhou M; Chen W; Jiang W
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Feb; 32(1):39-44. PubMed ID: 38387897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.